## Mechanism: 
- human IgG4-κ monoclonal antibody: binds to the IL-17A cytokine and IL17A/F heterodimers➔ inhibiting the interaction with the IL-17A receptor. 
## Indications: 
- moderate to severe plaque psoriasis, adults with PsA, psoriatic arthritis 
## Adverse Effects: 
- upper respiratory tract infections, inflammatory bowel disease